Jean Bertoldo

Team Leader at @KidsCancerInst | Chemical Biology and Target-Based Drug Design Group. Conjoint Senior Lecturer/Assist. Prof. @UNSWMedicine

[Jean Bertoldo @jean_bertoldo]

Super happy, it is both a privilege and a great responsability, but oh boy! the satisfaction, the excitment is beyond words. Check out, my group is finally here. #newPI https://t.co/q9O6O1Hkrh

[Retraction Watch @RetractionWatch]

“French physicist and media star loses doctorate after plagiarism investigation” found “copy-pasted material” in two-thirds of his thesis.
https://t.co/BnN5UPfrMl

https://t.co/VFDMohWzUc

[Jean Bertoldo @jean_bertoldo]

The team is growing. Welcome Montana and Elliot. 🤜🏻🤛🏻👨🏽‍🔬👨🏼‍🔬👩🏼‍🔬👩🏽‍🔬👨🏻‍🔬🧑🏽‍🔬 @KidsCancerInst @chadtough

[Jean Bertoldo @jean_bertoldo]

What an amazing event. Thank you @chadtough for such an incredible experience and for funding our work @KidsCancerInst. Together in the fight against DIPG.

[Jean Bertoldo @jean_bertoldo]

Really happy to be in my first @chadtough Research Workshop. Looking foward to meet the community, and establish new collaborations.

[Jean Bertoldo @jean_bertoldo]

The team is ready to go. Touring our new home in the almost finished MCCCC. Let's roll.

[Michelle Monje 🟦 @michelle_monje]

1/ Delighted to share the published version of this work from brilliant #CancerNeuroscience post-doc @TaraBarronPhD detailing GABAergic neuron-to-glioma synapses in #DIPG/#DMG. 🧵
Open access link:
https://t.co/n6kvjrVrjb

[Jean Bertoldo @jean_bertoldo]

The CBDD lab at #CCIResSymp @KidsCancerInst. And no, we didn't coordinate the dress code🤣🤣. Congrats to Josh on his oustanding talk on how we are using unnorthodox methods to target DMGs

[Jean Bertoldo @jean_bertoldo]

@charles_debock @NatureComms @KidsCancerInst Fantastic work @charles_debock! Congrats to the team!!👏🏻👏🏻👏🏻

[Jean Bertoldo @jean_bertoldo]

Today we welcome @DonaAnnJOHNS1 who joins my lab at @KidsCancerInst as our new Research Officer. Dona expertise in paediatric oncology and epigenetics is timely in our efforts to develop a targeted therapy for DIPG.

[Jean Bertoldo @jean_bertoldo]

Fantastic achievement and well deserved. Congrats🙏🏻

[Childrens Cancer Institute @KidsCancerInst]

We’re thrilled to celebrate the appointment of four of our incredible researchers to Associate Professor.
Join us in congratulating these extraordinary researchers: @charles_debock @EmmyFleuren @FaValdesMora & Michelle Henderson

[Jean Bertoldo @jean_bertoldo]

Looking for a medicinal chemist and a research assistant to join my lab at @KidsCancerInst. Please DM me if you are interested in cancer drug discovery and paediatric CNS tumours.

[Jean Bertoldo @jean_bertoldo]

Super happy. News on our research in #DIPG @KidsCancerInst and recent funding from @chadtough in my native language. 😊

[SBS Portuguese @sbsportuguese]

Já pensou poder tratar um câncer sem ter que lidar com os efeitos colaterias dos tratamentos atuais?

Austrália tem o único grupo de pesquisa para medicamento que poderá ser alternativa à quimioterapia.
https://t.co/HG7ZURzm8z

[Childrens Cancer Institute @KidsCancerInst]

A bold research project at @KidsCancerInst that could lead to the first-ever effective drug to treat deadly brain cancer, #DIPG, received a major boost this month, with a $US400,000 grant awarded to @Jean_Bertoldo by the US-based charity, @ChadTough. https://t.co/dWDZ5tcdPO

[Jean Bertoldo @jean_bertoldo]

@Hakanzt50881607 https://t.co/N01cOOCHpL

[Jean Bertoldo @jean_bertoldo]

Happy to present a lightning session on our work on targeting and modulating H3K27M activity in DIPG at #ASMRNSWASM2024 @TheASMR1 @KidsCancerInst

[Jean Bertoldo @jean_bertoldo]

We are recruiting! A Research Officer position to work on our recently funded @chadtough grant @KidsCancerInst. Interested in cancer drug discovery and paediatric brain cancer? Please follow the links. https://t.co/wjuUfT6yB1
Research Officer (https://t.co/AqLqlql7Qx)

[ChadTough Defeat DIPG Foundation @chadtough]

NEW INVESTIGATOR GRANT:
Dr. Jean Bertoldo, Children’s Cancer Institute

(Co-funded by the Violet Foundation)

[Jean Bertoldo @jean_bertoldo]

Super happy and grateful to @chadtough for funding our work on developing H3K27M-targeting chemical probes. Attacking the Achilles' heel of DIPG might be the crucial step toward eradicating this incurable cancer. @KidsCancerInst #NewInvestigatorGrant

[Jean Bertoldo @jean_bertoldo]

@EmmyFleuren @TheASMR1 @KidsCancerInst Thank you Emmy. Congratulations to you too. Well deserved award.😁

[Nature Reviews Drug Discovery @NatRevDrugDisc]

Chromatin-targeted drug discovery at “a very special moment” https://t.co/PTtXHQsXnx

Cigall Kadoch, a researcher at Dana-Farber Cancer Institute & co-founder of Foghorn Therapeutics, discusses the case for a new wave of epigenetic drugs targeting chromatin remodelling complexes